To better understand the degradation mode of the MYC protein in colon cancer cells, colon cancer HCT116 or SW620 cells were treated with MG132 (a proteasome inhibitor) or chloroquine (CQ, an autophagy inhibitor), respectively. This evidence concerns the gene MYC and malignant colon neoplasm.